MDLN vs. MOH: Medline vs. Molina Healthcare Stock Comparison

Company Profile

Medline (MDLN) and Molina Healthcare (MOH) both fall under the Health Care Equipment & Services industry group, but MDLN is classified in Health Care Equipment & Supplies while MOH is classified in Health Care Providers & Services.

Molina Healthcare (MOH) has been public since July 2, 2003, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Molina Healthcare (MOH) has a non-negative beta of 0.73.

Risk-Adjusted Performance

Risk-Return Positioning

Both MDLN and MOH need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Molina Healthcare (MOH) reports a negative ROE of -1.15%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Medline (MDLN) reports 4.85%, ranking against industry peers normally.

Molina Healthcare (MOH) reports a negative net margin of -0.11%, usually indicating a net loss over the period. Meanwhile Medline (MDLN) reports 1.85%, ranking against industry peers normally.

Both Medline (MDLN) at 5.22% and Molina Healthcare (MOH) at 1.00% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Only one side can be read here: Molina Healthcare (MOH) reports revenue growth of 11.75%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Medline (MDLN) at 117.38% delivers above-range EPS growth, while Molina Healthcare (MOH) at -56.32% falls into the bottom quartile — a wide split in earnings momentum.

Growth Metrics

Financial Strength

Molina Healthcare (MOH) at 1.69 keeps current ratio within its industry’s typical mid-range, while Medline (MDLN) at 4.04 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Medline (MDLN) at 0.65 carries an industry-typical debt-to-equity mix, while Molina Healthcare (MOH) at 0.95 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Neither Medline (MDLN) nor Molina Healthcare (MOH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Medline (MDLN) nor Molina Healthcare (MOH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Medline (MDLN) trades at 90.09 times trailing earnings, ranked against its peers, while Molina Healthcare (MOH) has no P/E ratio this period.

Molina Healthcare (MOH) at 0.26 sits in the cheaper P/S ratio quartile while Medline (MDLN) at 1.70 prices around its industry’s middle — MOH costs less per dollar of sales, though read it alongside growth and margins.

On P/B ratio, both Medline (MDLN) at 2.95 and Molina Healthcare (MOH) at 2.62 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics